Daxor (DXR) Corporate presentation summary

Mission and vision

• Aims to advance healthcare by enabling optimal fluid management through blood volume analysis.

• Envisions optimal blood volume for all patients.

Market opportunity and clinical need

• Addresses a 134M+ patient market in the U.S. for conditions like heart failure, hypertension, sepsis, and anemia.

• Blood volume derangement is central to many acute and chronic conditions, impacting both inpatient and outpatient care.

• Current assessment methods are often inaccurate, costly, and invasive, leading to suboptimal outcomes.

Technology and product offering

• Operates a 20,000 SF R&D and production facility capable of producing 400+ analyzers and 200,000 test kits annually.

• Sells Volumex® test kits used with BVA analyzers, creating a scalable recurring revenue stream.

• New hand-held BVA analyzer FDA-cleared in August 2025, delivers results within 30 minutes and is suitable for hospital and ambulatory settings.

• Offers ezBVA lab service for next-day results without capital investment.